Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
2004 1
2005 1
2010 1
2012 1
2013 5
2014 1
2016 2
2017 1
2019 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Anti-fertility vaccines.
Talwar GP, Raghupathy R. Talwar GP, et al. Vaccine. 1989 Apr;7(2):97-101. doi: 10.1016/0264-410x(89)90043-1. Vaccine. 1989. PMID: 2665354 Review.
The vaccines react against follicle stimulating hormone (FSH), luteinizing hormone (LH), and gonadotropin releasing hormone (GnRH). ...The principle of anti-hCG vaccine is to induce antibodies which can bind to hCG and render it biologically inactive. ...
The vaccines react against follicle stimulating hormone (FSH), luteinizing hormone (LH), and gonadotropin releasing hormone (GnRH). . …
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.
Lutchman Singh K, Davies M, Chatterjee R. Lutchman Singh K, et al. Hum Reprod Update. 2005 Jan-Feb;11(1):69-89. doi: 10.1093/humupd/dmh052. Epub 2004 Nov 29. Hum Reprod Update. 2005. PMID: 15569700 Review.
Special emphasis is placed on patients with cancer, including the pathophysiology of gonadal damage following chemotherapy, fertility preservation and the potential role of ORT. Baseline parameters of ovarian reserve [FSH LH, estradiol, inhibin B and anti-Mullerian …
Special emphasis is placed on patients with cancer, including the pathophysiology of gonadal damage following chemotherapy, fertility preser …
Anti-mullerian hormone: a new marker of ovarian function.
Dayal M, Sagar S, Chaurasia A, Singh U. Dayal M, et al. J Obstet Gynaecol India. 2014 Apr;64(2):130-3. doi: 10.1007/s13224-013-0482-3. Epub 2013 Dec 3. J Obstet Gynaecol India. 2014. PMID: 24757342 Free PMC article.

OBJECTIVES: The aim of this study was to determine day 3 Serum AMH, FSH, LH, Estradiol (E2), Inhibin B levels, ovarian volume, and antral follicular count to assess ovarian function. ...RESULTS: With advancing age, Serum AMH level (p < 0.0001), AFC (p < 0.05), ovaria

…
OBJECTIVES: The aim of this study was to determine day 3 Serum AMH, FSH, LH, Estradiol (E2), Inhibin B levels, ovarian volume, and an …
Late presentation of Swyer syndrome: A case report.
Pathak S, Raj G, Pratap R, Singh S. Pathak S, et al. Radiol Case Rep. 2023 Jul 12;18(9):3295-3298. doi: 10.1016/j.radcr.2023.06.061. eCollection 2023 Sep. Radiol Case Rep. 2023. PMID: 37497464 Free PMC article.
Possibility of complete gonadal dysgenesis was given which was further confirmed by the hormonal assay that showed hypergonadotropic-hypogonadism with raised serum follicular stimulating hormone (FSH) and serum luteinizing hormone (LH) levels and a low estradiol, low testo …
Possibility of complete gonadal dysgenesis was given which was further confirmed by the hormonal assay that showed hypergonadotropic-hypogon …
Vaccines for control of fertility and hormone dependent cancers.
Talwar GP, Singh O, Pal R, Chatterjee N. Talwar GP, et al. Int J Immunopharmacol. 1992 Apr;14(3):511-4. doi: 10.1016/0192-0561(92)90183-l. Int J Immunopharmacol. 1992. PMID: 1618603 Review.
Following suitable experimental and toxicology studies, the vaccine is currently in Phase I/Phase II clinical trials in patients of prostate carcinoma. Where antibody GnRH antibodies were induced, the LH, FSH and testosterone levels declined. This was accompanied by a redu …
Following suitable experimental and toxicology studies, the vaccine is currently in Phase I/Phase II clinical trials in patients of prostate …
Evaluation of Dehydroepiandrosterone Supplementation on Diminished Ovarian Reserve: A Randomized, Double-Blinded, Placebo-Controlled Study.
Agarwal R, Shruthi R, Radhakrishnan G, Singh A. Agarwal R, et al. J Obstet Gynaecol India. 2017 Apr;67(2):137-142. doi: 10.1007/s13224-016-0941-8. Epub 2016 Sep 19. J Obstet Gynaecol India. 2017. PMID: 28405122 Free PMC article.
Post-supplementation 12 weeks, D2/3 age-specific follicle-stimulating hormone (FSH), anti-mullerian hormone (AMH) levels, and antral follicle count (AFC), were repeated to evaluate response. ...CONCLUSIONS: A significant improvement in AMH levels pre- and post-suppl …
Post-supplementation 12 weeks, D2/3 age-specific follicle-stimulating hormone (FSH), anti-mullerian hormone (AMH) levels, and …
Effect of antitubercular treatment on ovarian function in female genital tuberculosis with infertility.
Sharma JB, Sneha J, Singh UB, Kumar S, Roy KK, Singh N, Dharmendra S. Sharma JB, et al. J Hum Reprod Sci. 2016 Jul-Sep;9(3):145-150. doi: 10.4103/0974-1208.192050. J Hum Reprod Sci. 2016. PMID: 27803581 Free PMC article.
The ovarian function tests were performed on day 2/3 as follicle-stimulating hormone (FSH) levels and anti-Mullerian hormone (AMH) levels. Ovarian dimensions (length, width, and depth) were measured using a transvaginal ultrasound. ...RESULTS: There was a significan …
The ovarian function tests were performed on day 2/3 as follicle-stimulating hormone (FSH) levels and anti-Mullerian hormone ( …
Development of B cell epitopes-based enzyme linked immune sorbent assay for detection of bovine anti-Mullerian hormone.
Pal P, Aggarwal A, Rajput YS, Deb R, Joshi VG, Verma AK, Haldar A, Singh I, Grewal S, De S. Pal P, et al. 3 Biotech. 2023 Jul;13(7):241. doi: 10.1007/s13205-023-03622-y. Epub 2023 Jun 18. 3 Biotech. 2023. PMID: 37342511
The test was selective since it did not bind to AMH-related growth and differentiation factors (LH and FSH) or non-related components (BSA, progesterone). The intra-assay CV was 5.67%, 3.12%, 4.94%, 3.61% and 4.27% for 72.44, 183.11, 368.24, 522.24 and 732.25 pg/ml AMH lev …
The test was selective since it did not bind to AMH-related growth and differentiation factors (LH and FSH) or non-related components …
"Anti-Mullerian Hormone: Marker for Ovarian Response in Controlled Ovarian Stimulation for IVF Patients": A First Pilot Study in the Indian Population.
Singh N, Malik E, Banerjee A, Chosdol K, Sreenivas V, Mittal S. Singh N, et al. J Obstet Gynaecol India. 2013 Aug;63(4):268-72. doi: 10.1007/s13224-012-0318-6. Epub 2013 Feb 22. J Obstet Gynaecol India. 2013. PMID: 24431654 Free PMC article.
OBJECTIVE: To measure the levels of early follicular phase Anti-Mullerian hormone (AMH) in Indian patients of IVF and to evaluate the AMH as a predictive marker of ovarian response in assisted reproductive technology outcome. ...The discriminant analysis was done to compar …
OBJECTIVE: To measure the levels of early follicular phase Anti-Mullerian hormone (AMH) in Indian patients of IVF and to evaluate the …
Ovarian Sensitivity Index (OSI): Validating the Use of a Marker for Ovarian Responsiveness in IVF.
Yadav V, Malhotra N, Mahey R, Singh N, Kriplani A. Yadav V, et al. J Reprod Infertil. 2019 Apr-Jun;20(2):83-88. J Reprod Infertil. 2019. PMID: 31058052 Free PMC article.
CONCLUSION: The present study showed that OSI appears to be a highly reliable index of ovarian responsiveness to recombinant FSH and can be useful to estimate the FSH dose....
CONCLUSION: The present study showed that OSI appears to be a highly reliable index of ovarian responsiveness to recombinant FSH and …
14 results